$0.9 Billion Global Benign Prostatic Hyperplasia Treatment Devices and Equipment Market Size, Growth, Segmentation And Forecast Report
The Business Research Company’s Benign
Prostatic Hyperplasia Treatment Devices and Equipment Market covers
market characteristics, size and growth, segmentation, regional and country
breakdowns, competitive landscape, market shares, trends and strategies for
this market.
The benign prostatic hyperplasia
(BPH) treatment devices and equipment market consists of sales of benign
prostatic hyperplasia (BPH) treatment devices and equipment and related
services. Benign prostatic hyperplasia or benign prostatic hypertrophy is a
condition of an enlarged prostate gland which causes blockade of urethra, the
tube that carries urine from the bladder. The market is segmented into
resectoscopes, radiofrequency ablation device, urology lasers, prostatic stents
and implants.
Major players in the market are Karl Storz, Lumenis, Olympus, Urologix and
Boston scientific Inc.
Benign Prostatic Hyperplasia
(BPH) also called Prostate Gland Enlargement (PGE), is a condition where
patient suffers from uncomfortable urinary symptoms. Due to rising prevalence
of Benign Prostatic Hyperplasia (BPH), demand for the BPH treatment devices and
equipment's is on a steady rise as the number of BPH cases increases the demand
for devices will also increase. For example, in the USA by 2018, more than 8
million men are suffering from Benign Prostatic Hyperplasia (BPH) and globally
around 22 million men have been diagnosed with moderate to severe symptoms of
BPH. Therefore, with number of BPH cases on the steady rise, the demand for BPH
treatment devices and equipment is also expected to grow.
The side effects suffered by the
patients after a BPH procedure is one of the major restraints for BPH device
and equipment market. For example, most common side effects of a BPH surgery
includes, urinary incontinence, discomfort during urination and difficulty in
completely emptying the bladder. The patients suffering from BPH does not
prefer surgical procedures (till the stage it can be avoided) due to these side
effects, therefore decreasing the demand of surgical procedures, which in turn
limits the demand for devices used by end users like hospitals, clinics and
ambulatory surgical centers.
View complete Report: https://www.thebusinessresearchcompany.com/report/benign-prostatic-hyperplasia-bph-treatment-devices-and-equipment-global-market-report
Prostatic Astery Embolization (PAE) is one of the latest
developments in the market for Benign Prostatic Hyperplasia (BPH) treatment
device and equipment. PAE is a minimally invasive treatment that assists in
reducing the symptoms observed in urinary tract. The PAE procedure is done
using X-rays and other advanced imaging to observe the tumor inside the body
and accordingly treat it without any surgery. This technique results in reduced
complication in the treatment of BPH and thus is said to be a major development
in the market of BPH treatment. Leading companies such as Boston scientifics,
UNC healthcare, and Spire healthcare have been investing in the market for PAE.
Browse Year End
Discounted Reports Offered By TBRC @ https://www.thebusinessresearchcompany.com/discounted-reports.aspx
About Us:
The Business Research Company is a Business Intelligence
Company which excels in company, market and consumer research. It has offices
in the UK, the US and India and a network of trained researchers in 15
countries globally.
Contact Information:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow us on LinkedIn: https://in.linkedin.com/company/the-business-research-company
View Our Latest Press Releases: https://www.thebusinessresearchcompany.com/press-release.aspx
Comments
Post a Comment